Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis

Elvia García-López1, Juan J Carrero, Mohamed E Suliman

  • 1Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Insights

Patients undergoing peritoneal dialysis (PD) face significant cardiovascular risks due to uremia and PD-related factors. This review explores inflammation, insulin resistance, and genetics in PD patients to improve cardiovascular outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Patients on peritoneal dialysis (PD) exhibit a high prevalence of cardiovascular disease.
  • Cardiovascular risk factors are amplified by the uremic environment, including inflammation, oxidative stress, and mineral imbalances.
  • Diabetes mellitus and hypertension are common comorbidities that accelerate kidney disease and cardiovascular progression.

Purpose of the Study:

  • To review recent advancements in cardiovascular research concerning the PD population.
  • To discuss emerging therapy trends for managing cardiovascular risk in PD patients.
  • To highlight the impact of specific factors like inflammation, insulin resistance, and genetics on cardiovascular health in PD.

Main Methods:

  • Literature review of recent findings in cardiovascular research on PD patients.
  • Analysis of factors associated with PD therapy that influence cardiovascular risk.
  • Emphasis on the roles of inflammation, insulin resistance, homocysteinemia, dyslipidemia, vascular calcification, and genetics/epigenetics.

Main Results:

  • PD patients face multifaceted cardiovascular risks from both uremic milieu and PD treatment itself.
  • Factors such as altered lipid profiles, hyperinsulinemia, and advanced glycation end-products can increase cardiovascular risk.
  • Conversely, PD may offer benefits through improved blood pressure control and anemia management.

Conclusions:

  • Understanding the complex interplay of factors influencing cardiovascular risk in PD is crucial.
  • Targeting inflammation, insulin resistance, dyslipidemia, and genetic predispositions may mitigate cardiovascular complications.
  • Further research and tailored therapeutic strategies are needed to optimize cardiovascular health in PD patients.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...